Collectively, these findings highlight FSTL1’s pivotal role in mediating quercetin’s anti-fibrotic effects, offering new perspectives on quercetin’s therapeutic potential in pulmonary fibrosis. The gene discussed is FSTL1; the disease is pulmonary fibrosis.